Ignite Creation Date:
2025-12-24 @ 5:59 PM
Ignite Modification Date:
2026-01-03 @ 6:03 PM
Study NCT ID:
NCT00671268
Status:
COMPLETED
Last Update Posted:
2013-11-08
First Post:
2008-04-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Pollen Adsorbed Onto Aluminium-hydroxide in Patients With IgE-mediated Allergic Rhinoconjunctivitis +/- Controlled Asthma
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'interventionBrowseModule': {'meshes': [{'id': 'D012964', 'term': 'Sodium'}], 'ancestors': [{'id': 'D008672', 'term': 'Metals, Alkali'}, {'id': 'D004602', 'term': 'Elements'}, {'id': 'D007287', 'term': 'Inorganic Chemicals'}, {'id': 'D019565', 'term': 'Metals, Light'}, {'id': 'D008670', 'term': 'Metals'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE3'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'DOUBLE', 'whoMasked': ['PARTICIPANT', 'INVESTIGATOR']}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 256}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2008-03'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2013-11', 'completionDateStruct': {'date': '2013-03', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2013-11-07', 'studyFirstSubmitDate': '2008-04-23', 'studyFirstSubmitQcDate': '2008-05-02', 'lastUpdatePostDateStruct': {'date': '2013-11-08', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2008-05-05', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2012-03', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Change of Symptom and Medication score', 'timeFrame': 'during the baseline and the following two pollen seasons'}]}, 'oversightModule': {'oversightHasDmc': False}, 'conditionsModule': {'keywords': ['Grass pollen allergy', 'specific immunotherapy'], 'conditions': ['Rhinoconjunctivitis']}, 'referencesModule': {'seeAlsoLinks': [{'url': 'http://www.allergopharma.de', 'label': 'Leader in specific allergy research and therapy'}, {'url': 'https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003208-37/DE', 'label': 'Click here for information about this trial in the European Clinical Trials Register'}]}, 'descriptionModule': {'briefSummary': 'Efficacy and Safety from a high-dosed subcutaneous recombinant preparation'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT'], 'maximumAge': '60 Years', 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Allergic rhinoconjunctivitis attributable to grass pollen\n* Positive SPT\n* Positive EAST\n* Positive provocation test\n\nExclusion Criteria:\n\n* serious disease\n* other perennial allergies'}, 'identificationModule': {'nctId': 'NCT00671268', 'acronym': 'AMETHYST', 'briefTitle': 'Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Pollen Adsorbed Onto Aluminium-hydroxide in Patients With IgE-mediated Allergic Rhinoconjunctivitis +/- Controlled Asthma', 'organization': {'class': 'INDUSTRY', 'fullName': 'Allergopharma GmbH & Co. KG'}, 'officialTitle': 'Multicentre, Multinational Randomised DBPC Clinical Trial for Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Pollen Adsorbed Onto Aluminium-hydroxide in Patients With IgE-mediated Allergic Rhinoconjunctivitis +/- Controlled Asthma', 'orgStudyIdInfo': {'id': 'AL0704rP'}, 'secondaryIdInfos': [{'id': '2007-003208-37', 'type': 'EUDRACT_NUMBER'}]}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': '1', 'description': 'strict subcutaneous', 'interventionNames': ['Biological: AL0704rP']}, {'type': 'PLACEBO_COMPARATOR', 'label': '2', 'description': 'strict subcutaneous', 'interventionNames': ['Biological: Placebo']}], 'interventions': [{'name': 'AL0704rP', 'type': 'BIOLOGICAL', 'otherNames': ['"na"'], 'description': 'strict subcutaneous', 'armGroupLabels': ['1']}, {'name': 'Placebo', 'type': 'BIOLOGICAL', 'otherNames': ['"na"'], 'description': 'strict subcutaneous', 'armGroupLabels': ['2']}]}, 'contactsLocationsModule': {'locations': [{'city': 'Reinbek', 'country': 'Germany', 'facility': 'Allergopharma GmbH & Co. KG', 'geoPoint': {'lat': 53.51703, 'lon': 10.2488}}], 'overallOfficials': [{'name': 'Margitta Worm, Professor', 'role': 'PRINCIPAL_INVESTIGATOR'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Allergopharma GmbH & Co. KG', 'class': 'INDUSTRY'}, 'responsibleParty': {'type': 'SPONSOR'}}}}